Market Research Logo

Netherlands Pharmaceuticals & Healthcare Q4 2019

Netherlands Pharmaceuticals & Healthcare Q4 2019

Key View:

We expect the Dutch pharmaceutical market to continue its tedious recovery in 2019 and onwards, with growth slowedby the patent cliff and restrictions on medicine prices under the Medicines Prices Act. We expect innovative drug sales will continueto decline in the short term, with growth in this sub-sector returning over the longer term as the population ages and chronicillnesses rise. However, the government will likely continue to favour lower-value generic medicines as well as other price reducingmeasures as a means of controlling spiralling healthcare costs.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Netherlands Risk/Reward Index Score
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Pharming Group
Qiagen
Sanofi
DSM
Netherlands Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report